Proof of Usefulness Report

Strados Labs

Analysis completed on 1/30/2026

+588
Proof of Usefulness Score
Industry Mainstay

Strados Labs is a verified Series A medical technology company (raised ~$10M) with an FDA 510(k) cleared wearable device (RESP) for respiratory monitoring. The company has a team of ~50 and strong traction in clinical trials and pharmaceutical partnerships. However, the submission itself contained significantly inaccurate and hyperbolic data (e.g., claiming 'most people have used my product' and 'everyone' as the audience), which severely reduced the Response Quality and Traction Verification scores despite the company's actual success. The high score reflects the verified medical utility and technical innovation of the FDA-cleared hardware.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+212.5
Audience Reach Impact+80.0
Technical Innovation+144.0
Evidence Of Traction+120.0
Market Timing Relevance+80.0
Functional Completeness+2.5
Subtotal+639
Usefulness Multiplierx0.92
Final Score+588

Project Details

Project URL
Description
Strados Labs was built by asthma patients, doctors and engineers as a way to solve a major problem in respiratory care and research. 49% of respiratory patients don't perceive symptoms like wheezing and coughing accurately which delays care management, increase patient cost and makes clinical research more challenging. In the COVID-19 are, it is more critical than ever that we accurately identify worsening pulmonary function to avoid ER events, spread of infectious respiratory disease and save lives. \n\nThe RESP technology is the first FDA 510(k) cleared wearable wireless lung sound detection system that is cloud-based and patient-friendly. Along with our proprietary algorithms, the RESP technology is uniquely positioned to change the way to manage respiratory health in the U.S. and across the world. \n\nToday, we are focused on selling into clinical research organizations and pharmaceutical companies to provide them with enhances understanding pulmonary status using our bioacoustic sensor and algorithms. Over time, we will transition to remote-care enablement and telehealth expansion as we scale our sensor-based AI for unique clinical insights.\n\nJoin our team today if you want to be on the front-lines of a game changing technology solution that can save lives.

Algorithm Insights

Market Position
Strong market validation with clear user adoption patterns
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline